Literature DB >> 18246736

Chest computerized tomography scan findings in 74 children with tuberculous meningitis in southeastern Turkey.

Ahmet Yaramiş1, Yaşar Bükte, Selahattin Katar, M Nuri Ozbek.   

Abstract

This prospective study was done over seven years from 1996 to 2003 to investigate the chest computed tomography scan findings along with other radiologic examinations that included chest roentgenography and cranial computed tomography in children with tuberculous meningitis (TBM). Chest roentgenography demonstrated abnormal findings in 32 cases (43%) (hilar adenopathy, 32%; miliary pattern, 18%; bronchopneumonic infiltrate, 24%), while chest computerized tomography was abnormal in 65 cases (88%; p<0.005): mediastinal and hilar lymphadenopathy were present in 46% (p<0.005); miliary pattern, in 23% (p<0.05); and bronchopneumonic infiltrate, in 23% (p<0.05). Cranial computerized tomography was abnormal in 68 cases (92%). Chest computerized tomography scan helps establish the diagnosis of TBM when chest radiography is normal or inconclusive, and it is useful in assessing children with suspected TBM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18246736

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  3 in total

1.  Approach to the diagnosis and management of tuberculous meningitis.

Authors:  Scott W Sinner
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

Review 2.  Advances in the Diagnosis and Management of Tubercular Meningitis in Children.

Authors:  Himani Bhasin; Medha Goyal; Suvasini Sharma
Journal:  Indian J Pediatr       Date:  2019-12-04       Impact factor: 1.967

3.  Clinical, radiological and laboratory findings in 185 children with tuberculous meningitis at a single centre and relationship with the stage of the disease.

Authors:  Ali Güneş; Ünal Uluca; Fesih Aktar; Çapan Konca; Velat Şen; Aydın Ece; Salih Hoşoğlu; Mehmet Ali Taş; Fuat Gürkan
Journal:  Ital J Pediatr       Date:  2015-10-15       Impact factor: 2.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.